These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 26016241)
21. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Huber SA Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288 [TBL] [Abstract][Full Text] [Related]
25. Necroptosis may be a novel mechanism for cardiomyocyte death in acute myocarditis. Zhou F; Jiang X; Teng L; Yang J; Ding J; He C Mol Cell Biochem; 2018 May; 442(1-2):11-18. PubMed ID: 28887702 [TBL] [Abstract][Full Text] [Related]
26. Astragalus Root dry extract restores connexin43 expression by targeting miR-1 in viral myocarditis. Wang Y; Li J; Xuan L; Liu Y; Shao L; Ge H; Gu J; Wei C; Zhao M Phytomedicine; 2018 Jul; 46():32-38. PubMed ID: 30097120 [TBL] [Abstract][Full Text] [Related]
27. Upregulated microRNA-214 enhances cardiac injury by targeting ITCH during coxsackievirus infection. Chen ZG; Liu H; Zhang JB; Zhang SL; Zhao LH; Liang WQ Mol Med Rep; 2015 Jul; 12(1):1258-64. PubMed ID: 25815880 [TBL] [Abstract][Full Text] [Related]
28. [An experimental study on inhibitory effect of xinjierkang granules on virus myocarditis]. Wang QM; Chen GL; Wang YJ; Wang HS; Gao MH; Gong YZ Zhongguo Zhong Yao Za Zhi; 2000 May; 25(5):293-6. PubMed ID: 12512454 [TBL] [Abstract][Full Text] [Related]
29. Electrophysiological and pathological observations on experimental coxsackie B-3 viral myocarditis in mice. Yang YZ; Guo Q; Zhou TS; Zhang J; Li L; Jin PY; Wu WZ; Shen JY; Yang JH; Peng BZ Chin Med J (Engl); 1993 Feb; 106(2):100-4. PubMed ID: 8389271 [TBL] [Abstract][Full Text] [Related]
30. Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis. Ruppert V; Meyer T; Pankuweit S; Jonsdottir T; Maisch B Cardiovasc Pathol; 2008; 17(2):81-92. PubMed ID: 18329552 [TBL] [Abstract][Full Text] [Related]
31. Mutations in the 5' NTR and the Non-Structural Protein 3A of the Coxsackievirus B3 Selectively Attenuate Myocarditogenicity. Massilamany C; Gangaplara A; Basavalingappa RH; Rajasekaran RA; Vu H; Riethoven JJ; Steffen D; Pattnaik AK; Reddy J PLoS One; 2015; 10(6):e0131052. PubMed ID: 26098885 [TBL] [Abstract][Full Text] [Related]
32. Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. Pauschinger M; Rutschow S; Chandrasekharan K; Westermann D; Weitz A; Peter Schwimmbeck L; Zeichhardt H; Poller W; Noutsias M; Li J; Schultheiss HP; Tschope C Eur J Heart Fail; 2005 Jun; 7(4):444-52. PubMed ID: 15921778 [TBL] [Abstract][Full Text] [Related]
33. Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. Yue-Chun L; Li-Sha G; Jiang-Hua R; Peng-Lin Y; Jia-Feng L; Ji-Fei T; Peng C; Zhan-Qiu Y J Cardiovasc Pharmacol; 2008 Jan; 51(1):92-8. PubMed ID: 18209574 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis. Corsten MF; Papageorgiou A; Verhesen W; Carai P; Lindow M; Obad S; Summer G; Coort SL; Hazebroek M; van Leeuwen R; Gijbels MJ; Wijnands E; Biessen EA; De Winther MP; Stassen FR; Carmeliet P; Kauppinen S; Schroen B; Heymans S Circ Res; 2012 Aug; 111(4):415-25. PubMed ID: 22715471 [TBL] [Abstract][Full Text] [Related]
35. Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB/c mice. Jiang Y; Zhu Y; Mu Q; Luo H; Zhi Y; Shen X Antiviral Res; 2017 May; 141():133-139. PubMed ID: 28115196 [TBL] [Abstract][Full Text] [Related]
36. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis. Li J; Leschka S; Rutschow S; Schwimmbeck PL; Husmann L; Noutsias M; Westermann D; Poller W; Zeichhardt H; Klingel K; Tschope C; Schultheiss HP; Pauschinger M Eur J Pharmacol; 2007 Jan; 554(1):60-8. PubMed ID: 17113076 [TBL] [Abstract][Full Text] [Related]
37. Treatment of experimental Coxsackie B-3 viral myocarditis with Astragalus membranaceus in mice. Yang YZ; Jin PY; Guo Q; Wu WZ; Pu SY; Chen HZ; Yang JH; Wang KQ; Shi JY; Gong ZX Chin Med J (Engl); 1990 Jan; 103(1):14-8. PubMed ID: 2161724 [TBL] [Abstract][Full Text] [Related]
38. Panax Notoginseng Saponins Ameliorates Coxsackievirus B3-Induced Myocarditis by Activating the Cystathionine-γ-Lyase/Hydrogen Sulfide Pathway. Pan L; Zhang Y; Lu J; Geng Z; Jia L; Rong X; Wang Z; Zhao Q; Wu R; Chu M; Zhang C J Cardiovasc Transl Res; 2015 Dec; 8(9):536-44. PubMed ID: 26525047 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate coxsackievirus adenovirus receptor. Sharma M; Mishra B; Saikia UN; Bahl A; Ratho RK Indian J Med Res; 2017 Oct; 146(4):520-527. PubMed ID: 29434067 [TBL] [Abstract][Full Text] [Related]
40. Temporal changes in stem cells in the circulation and myocardium of mice with Coxsackie virus B3-induced myocarditis. Zhao L; Li S; Ge J; Sun A; Zou Y; Zhang S Microvasc Res; 2008 Apr; 75(3):358-66. PubMed ID: 18206181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]